×
Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Contrast Media Market Share

ID: MRFR/LS/0776-HCR
90 Pages
Rahul Gotadki
February 2026

Contrast Media Market Research Report Information By Type (Iodinated Contrast Media, Gadolinium-Based Contrast Media), By Form (Tablet, Powder, Liquid, Paste), By Procedures (X-ray/Computed Tomography, Magnetic Resonance Imaging), By Application (Cardiovascular Disease, Oncology, Gastrointestinal Disorders), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Contrast Media Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Methodology Download PDF

Market Share

Contrast Media Market Share Analysis

Many medical imaging procedures need contrast media, which drives the market. Companies in this industry utilize a variety of techniques to stay ahead of their competitors and grow their diagnostic imaging market share. There are several contrast agents sold for medical imaging equipment in the Contrast Media industry. These contrast compounds are utilized in X-rays, CT, MRI, and ultrasound studies. Businesses may increase market share by offering a range of products for various medical imaging processes. Innovative contrast agent formulations are essential for market competitiveness. Companies spend in R&D to create unique formulations to improve imaging, minimize side effects, and increase patient safety. New features and enhancements help distinguish products and attract customers. Developing solid connections with imaging equipment makers is crucial. Partnerships with X-ray, CT, and MRI manufacturers facilitate contrast media product integration into therapy. Businesses may enhance their market reach by coordinating their advertisements and ensuring interoperability. For Contrast Media workers, patient safety is paramount. Companies are creating contrast agents with less side effects to differentiate themselves from competition. A company may improve its market position and gain healthcare professionals' trust by focusing on safety. Due to the worldwide scope of medical imaging, it's important to strategically expand into new markets. Business development into new locations, distribution network creation, and worldwide regulatory clearances are all progressing. A strong presence in foreign countries expands a company's customer reach and positions it as a global leader. Due to the importance of contrast media in medical diagnostics, regulations must be followed. Businesses engage in quality assurance to comply with regulations. High-quality standards boost the brand's image and market position while appeasing regulators. Businesses target diagnostic imaging healthcare workers with instructional marketing. We will provide training programs, webinars, and seminars to educate practitioners on the latest contrast media technologies. These efforts help buyers realize the product's worth, which boosts sales. Contrast Media companies employ price competition to compete with growing healthcare costs. This may entail creating bundles with imaging equipment, offering discounts for large purchases, or offering affordable alternatives to healthcare institutions struggling to fulfill their financial responsibilities. Strategic pricing may enhance market share. As sustainability becomes more important, firms are integrating environmental activities into their commercial positioning. This includes researching ecologically friendly contrast media compositions, designing eco-friendly packaging, and eliminating product production waste. Businesses may win over environmentally conscious hospitals and doctors by demonstrating environmental sensitivity.

Author
Rahul Gotadki
Research Manager

He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

Get In Touch

Leave a Comment

FAQs

What is the current valuation of the Contrast Media Market as of 2024?

<p>The Contrast Media Market was valued at 6.74 USD Billion in 2024.</p>

What is the projected market valuation for the Contrast Media Market in 2035?

<p>The market is projected to reach 11.24 USD Billion by 2035.</p>

What is the expected CAGR for the Contrast Media Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Contrast Media Market during 2025 - 2035 is 4.76%.</p>

Which segment of the Contrast Media Market is expected to grow the most by 2035?

<p>Iodinated Contrast Media is anticipated to grow from 4.04 USD Billion in 2024 to 6.7 USD Billion by 2035.</p>

How do Gadolinium-Based Contrast Media valuations compare between 2024 and 2035?

<p>Gadolinium-Based Contrast Media is expected to increase from 2.7 USD Billion in 2024 to 4.54 USD Billion by 2035.</p>

What forms of contrast media are projected to see significant growth by 2035?

Liquid forms are expected to grow from 2.68 USD Billion in 2024 to 4.45 USD Billion by 2035.

Which medical procedures are driving the demand for contrast media?

X-ray/Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) are key procedures, with CT expected to grow from 3.5 USD Billion in 2024 to 5.8 USD Billion by 2035.

What applications are contributing to the growth of the Contrast Media Market?

Oncology is projected to grow from 2.68 USD Billion in 2024 to 4.4 USD Billion by 2035, indicating a strong demand in this area.

Who are the key players in the Contrast Media Market?

Key players include Bayer AG, GE Healthcare, and Bracco Imaging S.p.A., among others.

What is the expected growth trend for the Contrast Media Market in the coming years?

The market is likely to experience steady growth, driven by advancements in imaging technologies and increasing applications in various medical fields.

Market Summary

As per Market Research Future analysis, the Contrast Media Market Size was estimated at 6.74 USD Billion in 2024. The Contrast Media industry is projected to grow from 7.061 USD Billion in 2025 to 11.24 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 4.76% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Contrast Media Market is poised for substantial growth driven by technological advancements and increasing healthcare demands.

  • North America remains the largest market for contrast media, driven by advanced healthcare infrastructure and high diagnostic imaging rates. The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising healthcare investments and increasing patient populations. Iodinated contrast media continues to dominate the market, while gadolinium-based contrast media is experiencing rapid growth due to its efficacy in MRI procedures. Key market drivers include the rising incidence of chronic diseases and regulatory support for advanced imaging solutions.

Market Size & Forecast

2024 Market Size 6.74 (USD Billion)
2035 Market Size 11.24 (USD Billion)
CAGR (2025 - 2035) 4.76%
Largest Regional Market Share in 2024 North America

Major Players

<a href="https://www.bayer.com/en/products/products-from-A-to-Z">Bayer</a> AG (DE), GE Healthcare (US), Bristol-Myers Squibb Company (US), Bracco Imaging S.p.A. (IT), Fujifilm Holdings Corporation (JP), Siemens Healthineers (DE), Canon Medical Systems Corporation (JP), Hoffmann-La Roche Ltd (CH)

Market Trends

The Contrast Media Market is currently experiencing a dynamic evolution, driven by advancements in imaging technologies and an increasing demand for diagnostic procedures. The integration of artificial intelligence and machine learning into imaging modalities appears to enhance the accuracy and efficiency of contrast media applications. Furthermore, the growing prevalence of chronic diseases necessitates improved diagnostic capabilities, thereby propelling the market forward. As healthcare systems worldwide strive for better patient outcomes, the role of contrast agents in medical imaging becomes increasingly pivotal. In addition, the rising awareness regarding early disease detection and the importance of timely diagnosis seems to be influencing the demand for contrast media. Regulatory bodies are also playing a crucial role in ensuring the safety and efficacy of these agents, which may further bolster market growth. The ongoing research and development efforts aimed at creating innovative contrast agents that minimize adverse effects could potentially reshape the landscape of the Contrast Media Market in the coming years.

Technological Advancements in Imaging

The Contrast Media Market is witnessing a surge in technological innovations, particularly in imaging modalities such as MRI and CT scans. These advancements are likely to enhance the precision of diagnostic imaging, thereby increasing the reliance on contrast agents. 

Within this context, the diagnostic agents definition encompasses a diverse range of substances—including iodinated, gadolinium-based, and barium compounds—that temporarily alter how internal structures interact with imaging energy.

Growing Demand for Minimally Invasive Procedures

There appears to be a notable shift towards minimally invasive diagnostic and therapeutic procedures within the healthcare sector. This trend is likely to drive the demand for contrast media, as these agents are essential for visualizing internal structures during such procedures. The preference for less invasive options may lead to an increase in the utilization of contrast agents.

Focus on Patient Safety and Efficacy

Consolidation within the contrast agents’ market has led to more streamlined distribution networks, yet it also places a premium on manufacturers who can demonstrate superior safety profiles for patients with renal sensitivities.

Radiation-free Diagnosis

The portfolio of Bracco contrast media is recognized for its specialized offerings in ultrasound and MRI, positioning the company as a critical partner for hospitals shifting toward radiation-free diagnostic modalities.

Contrast Media Market Market Drivers

Rising Incidence of Chronic Diseases

The increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions is a primary driver of the Contrast Media Market. As these diseases require advanced imaging techniques for diagnosis and monitoring, the demand for contrast media is expected to rise. According to recent statistics, the incidence of cancer is projected to increase, leading to a higher need for imaging modalities like MRI and CT scans, which utilize contrast agents. This trend indicates a growing market for contrast media, as healthcare providers seek effective solutions for accurate diagnosis and treatment planning. Furthermore, the aging population is likely to exacerbate this trend, as older individuals are more susceptible to chronic conditions, thereby further propelling the demand for contrast media in medical imaging.

Increase in Diagnostic Imaging Procedures

The rising number of diagnostic imaging procedures is a crucial driver of the Contrast Media Market. As healthcare systems increasingly rely on imaging for accurate diagnosis, the demand for contrast media is likely to grow. Reports indicate that the number of CT and MRI scans performed annually has surged, reflecting a shift towards more comprehensive diagnostic approaches. This increase is attributed to the growing awareness of the importance of early disease detection and the advancements in imaging technology that facilitate these procedures. Consequently, the contrast media market is poised for growth, as healthcare providers seek to enhance the effectiveness of imaging studies through the use of high-quality contrast agents. This trend underscores the essential role of contrast media in modern diagnostic practices.

Growing Awareness of Preventive Healthcare

The increasing emphasis on preventive healthcare is driving the demand for diagnostic imaging, thereby influencing the Contrast Media Market. As patients and healthcare providers recognize the importance of early detection and intervention, the utilization of imaging techniques that require contrast media is likely to rise. Educational campaigns and public health initiatives are fostering a culture of preventive care, leading to more individuals seeking regular health screenings that incorporate advanced imaging. This trend is expected to boost the demand for contrast agents, as they play a critical role in enhancing the quality of imaging studies. Consequently, the contrast media market is positioned for growth, as it aligns with the broader shift towards preventive healthcare practices that prioritize early diagnosis and treatment.

Technological Innovations in Imaging Techniques

Technological advancements in imaging modalities are significantly influencing the Contrast Media Market. Innovations such as 3D imaging, hybrid imaging systems, and enhanced MRI techniques are driving the adoption of advanced contrast agents. These technologies improve diagnostic accuracy and patient outcomes, leading to an increased utilization of contrast media. For instance, the development of gadolinium-based contrast agents has revolutionized MRI imaging, providing clearer images and better diagnostic capabilities. The market for contrast media is expected to expand as healthcare facilities invest in state-of-the-art imaging technologies, which require sophisticated contrast agents to enhance image quality. This trend suggests a robust growth trajectory for the contrast media sector, as it adapts to the evolving landscape of medical imaging.

Regulatory Support for Advanced Imaging Solutions

Regulatory bodies are increasingly supporting the development and approval of advanced imaging solutions, which is positively impacting the Contrast Media Market. Initiatives aimed at expediting the approval process for new contrast agents and imaging technologies are likely to foster innovation and enhance market growth. For example, regulatory agencies have introduced frameworks that facilitate faster access to novel contrast media, ensuring that healthcare providers can utilize the latest advancements in imaging. This regulatory support not only encourages research and development but also enhances patient access to cutting-edge diagnostic tools. As a result, the contrast media market is expected to benefit from a more favorable regulatory environment, promoting the introduction of innovative products that meet the evolving needs of healthcare professionals.

Market Segment Insights

By Type: Iodinated Contrast Media (Largest) vs. Gadolinium-Based Contrast Media (Fastest-Growing)

<p>The Contrast Media Market is predominantly supported by Iodinated Contrast Media, which consistently holds the largest market share within the segment. This type accounts for a significant portion of the diagnostic imaging procedures, preferred for its effectiveness in enhancing the contrast of imaging results. In contrast, Gadolinium-Based Contrast Media, while smaller in share compared to Iodinated types, is witnessing a rapid increase in acceptance due to its favorable safety profile, particularly among patients with renal issues.</p>

<p>Contrast Media: Iodinated Contrast Media (Dominant) vs. Gadolinium-Based Contrast Media (Emerging)</p>

<p>Iodinated Contrast Media is widely regarded as the dominant type due to its extensive application in various imaging modalities, including X-rays and CT scans. Its high osmolarity offers enhanced visualization, which makes it a staple choice in clinical settings. On the other hand, Gadolinium-Based Contrast Media is emerging rapidly as a preferred alternative, especially in MRI procedures. It is known for its reduced risk of adverse reactions, making it highly appealing, particularly in patients with renal impairment. The increasing awareness and adoption of gadolinium media are driven by ongoing research showcasing its efficacy and safety, thereby augmenting its market growth.</p>

By Form: Liquid (Largest) vs. Tablet (Fastest-Growing)

<p>In the Contrast Media Market, liquid forms dominate market share due to their widespread applicability and effectiveness in imaging procedures. These products continue to be the preferred choice for many medical professionals because of their ease of administration and rapid action within the body. Tablets, while currently a smaller segment, are rapidly gaining traction as they offer convenience and improved patient compliance, positioning themselves as a viable alternative to traditional liquid forms.</p>

<p>Liquid (Dominant) vs. Tablet (Emerging)</p>

<p>Liquid contrast media is recognized for its superior efficacy in enhancing imaging results, with a broad range of applications in various diagnostic imaging modalities such as X-rays and CT scans. Its extensive utilization in hospitals fortifies its position as the dominant form in the market. On the other hand, tablet contrast media is emerging as a convenient option, particularly for patients who prefer an oral intake method. Its growth is propelled by advancements in formulation technology that enhance absorption and bioavailability, making it an appealing choice for both patients and healthcare providers.</p>

By Procedure: X-ray/CT (Largest) vs. MRI (Fastest-Growing)

<p>In the Contrast Media Market, X-ray/Computed Tomography (CT) holds the largest market share, representing a significant portion of the overall usage. This dominance is attributed to the widespread application of X-ray and CT imaging in various diagnostic procedures, making it a preferred choice among healthcare professionals. Meanwhile, Magnetic Resonance Imaging (MRI) is rapidly gaining traction, driven by its non-invasive nature and superior soft tissue contrast, appealing to an increasing number of clinicians and patients alike.</p>

<p>Imaging Technologies: X-ray/CT (Dominant) vs. MRI (Emerging)</p>

<p>X-ray/CT technology is well-established in the medical imaging field, known for its quick diagnostic capabilities and ongoing integration with digital technologies, which enhance image quality and patient safety. On the other hand, MRI is viewed as an emerging player in the market, particularly favored for its ability to provide detailed images of soft tissues without radiation. The increasing prevalence of chronic diseases necessitating precise imaging and the advancement of MRI technology are key drivers propelling its growth. As practitioners seek out improved diagnostic methods, MRI is poised to capture greater market share in the upcoming years, complementing the already dominant X-ray/CT segment.</p>

By Application: Cardiovascular Disease (Largest) vs. Oncology (Fastest-Growing)

<p>In the Contrast Media Market, the application segment is prominently led by cardiovascular disease applications, which represent the largest share. This segment benefits from the increasing prevalence of heart-related ailments, driving demand for effective diagnostic solutions. Additionally, oncology applications are witnessing accelerated growth, spurred by rising cancer incidences and innovative advancements in imaging techniques to enhance tumor detection and monitoring. As a result, the applications of contrast media in these areas capture significant market attention.</p>

<p>Cardiovascular Disease (Dominant) vs. Oncology (Emerging)</p>

<p>The cardiovascular disease segment remains dominant within the contrast media applications, aided by its extensive use in diagnostic imaging modalities that significantly improve patient outcomes. Cardiovascular procedures that utilize contrast media enhance visualization of the heart and blood vessels, which are crucial for accurate diagnosis and treatment planning. Conversely, the oncology segment is emerging rapidly, fueled by innovations in imaging technologies and targeted therapeutics. The increasing focus on early detection of cancers through advanced imaging methods highlights the growing adoption of contrast media, positioning it as a pivotal application in comprehensive cancer care.</p>

Get more detailed insights about Contrast Media Market Research Report - Global Forecast till 2035

Regional Insights

North America : Leading Innovation and Demand

North America is the largest market for contrast media, holding approximately 45% of the global share. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of chronic diseases, and rising demand for diagnostic imaging. Regulatory support from agencies like the FDA further catalyzes market expansion, ensuring safety and efficacy in contrast media products. The United States is the primary contributor, with significant investments in healthcare technology and research. Key players such as GE Healthcare and Bristol-Myers Squibb are prominent in this market, focusing on innovative solutions and partnerships. The competitive landscape is characterized by continuous advancements in imaging technologies, enhancing patient outcomes and driving market growth.

Europe : Regulatory Framework and Growth

Europe is the second-largest market for contrast media, accounting for about 30% of the global share. The region benefits from stringent regulatory frameworks that ensure high-quality standards in medical products. Increasing investments in healthcare infrastructure and a growing aging population are key drivers of demand. Countries like Germany and France are leading the market, supported by favorable reimbursement policies and technological advancements. Germany stands out as a major player, with significant contributions from companies like Bayer AG and Siemens Healthineers. The competitive landscape is robust, with a focus on innovation and collaboration among key players. The European market is also witnessing a rise in the adoption of advanced imaging techniques, further propelling growth in the contrast media sector.

Asia-Pacific : Emerging Market Potential

Asia-Pacific is an emerging powerhouse in the contrast media market, holding approximately 20% of the global share. The region's growth is fueled by increasing healthcare expenditure, rising awareness of diagnostic imaging, and a growing patient population. Countries like China and India are at the forefront, with significant investments in healthcare infrastructure and technology. Regulatory bodies are also enhancing their frameworks to support market growth. China is the largest market in the region, driven by a surge in demand for advanced imaging techniques. Key players such as Fujifilm Holdings and Canon Medical Systems are expanding their presence, focusing on innovative products tailored to local needs. The competitive landscape is evolving, with a mix of The Contrast Media Market share in this rapidly growing sector.

Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa region represents a growing market for contrast media, accounting for about 5% of the global share. The growth is driven by increasing healthcare investments, rising awareness of diagnostic imaging, and a growing population. Countries like South Africa and the UAE are leading the market, supported by government initiatives to improve healthcare access and quality. South Africa is a key player, with a focus on enhancing healthcare infrastructure and technology. The competitive landscape includes both local and international companies, with a growing emphasis on partnerships and collaborations. As the region continues to develop, the demand for advanced imaging solutions is expected to rise, presenting significant opportunities for market players.

Key Players and Competitive Insights

The Contrast Media Market is currently characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for diagnostic imaging. Key players such as Bayer AG (Germany), GE Healthcare (US), and Bracco Imaging S.p.A. (Italy) are at the forefront, each adopting distinct strategies to enhance their market presence. Bayer AG (Germany) focuses on innovation in contrast agents, particularly in the development of safer and more effective products, while GE Healthcare (US) emphasizes digital transformation and integration of AI in imaging technologies. Bracco Imaging S.p.A. (Italy) is actively pursuing regional expansion, particularly in emerging markets, to capitalize on the growing healthcare infrastructure. Collectively, these strategies not only enhance their competitive positioning but also contribute to a more robust market environment. In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. The market structure appears moderately fragmented, with several players vying for market share. However, the influence of major companies is significant, as they set industry standards and drive innovation. This competitive structure fosters an environment where smaller firms can thrive by focusing on niche markets or specialized products, thereby enhancing overall market dynamism. In August 2025, Bayer AG (Germany) announced a strategic partnership with a leading AI technology firm to develop advanced imaging solutions that enhance diagnostic accuracy. This collaboration is poised to leverage AI capabilities to improve the efficacy of contrast media, potentially revolutionizing patient outcomes in diagnostic imaging. The strategic importance of this partnership lies in its potential to position Bayer as a leader in the integration of AI within the contrast media sector, aligning with broader industry trends towards digitalization. In September 2025, GE Healthcare (US) launched a new line of contrast agents designed specifically for pediatric patients, addressing a critical gap in the market. This initiative not only demonstrates GE's commitment to patient safety but also reflects a growing trend towards personalized medicine. By focusing on the unique needs of pediatric patients, GE Healthcare is likely to enhance its market share and strengthen its brand loyalty among healthcare providers. In July 2025, Bracco Imaging S.p.A. (Italy) expanded its operations in Asia by establishing a new manufacturing facility in India. This move is strategically significant as it allows Bracco to tap into the rapidly growing healthcare market in the region, while also optimizing its supply chain. The establishment of local manufacturing capabilities is expected to reduce lead times and costs, thereby enhancing Bracco's competitive edge in the Asian market. As of October 2025, the Contrast Media Market is witnessing trends such as increased digitalization, sustainability initiatives, and the integration of AI technologies. Strategic alliances among key players are shaping the competitive landscape, fostering innovation and collaboration. Looking ahead, it appears that competitive differentiation will increasingly hinge on technological advancements and supply chain reliability, rather than solely on price. Companies that prioritize innovation and adapt to evolving market demands are likely to emerge as leaders in this rapidly changing environment.

Key Companies in the Contrast Media Market include

Industry Developments

October 2022: G.E. Healthcare's pharmaceutical diagnostics company announced a long-term agreement with the Chilean mining company Sociedad Quimica y Minera (SQM) de Chile S.A. to guarantee its supply of iodine, which is used in X-ray contrast media products. Vital components and computed tomography procedures around the world. As part of G.E. Healthcare's larger commitment and investment plan, this will help SQM expand its supply of iodine raw material year-on-year, producing an additional 30 Billion doses of iodine contrast media per year by 2025.

December 2021: The previously announced G.E. Healthcare acquisition of B.K. Medical was finalized. With this acquisition, G.E. Healthcare has enhanced its pre- and post-operative ultrasound capabilities to cover real-time surgical observation, a fast-growing and relatively new discipline.

Future Outlook

Contrast Media Market Future Outlook

The Contrast Media Market is projected to grow at a 4.76% CAGR from 2025 to 2035, driven by technological advancements, increasing diagnostic imaging demand, and rising healthcare expenditures.

New opportunities lie in:

  • <p>Development of AI-driven imaging solutions for enhanced diagnostic accuracy. Expansion into emerging markets with tailored contrast media products. Partnerships with healthcare providers for integrated imaging services.</p>

By 2035, the Contrast Media Market is expected to achieve robust growth, reflecting evolving healthcare needs.

Market Segmentation

Contrast Media Market Form Outlook

  • Liquid
  • Tablet
  • Powder
  • Paste

Contrast Media Market Type Outlook

  • Iodinated Contrast Media
  • Gadolinium-Based Contrast Media

Contrast Media Market Procedure Outlook

  • X-ray/Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)

Contrast Media Market Application Outlook

  • Cardiovascular Disease
  • Oncology
  • Gastrointestinal Disorders

Report Scope

MARKET SIZE 2024 6.74(USD Billion)
MARKET SIZE 2025 7.061(USD Billion)
MARKET SIZE 2035 11.24(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 4.76% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Bayer AG (DE), GE Healthcare (US), Bristol-Myers Squibb Company (US), Bracco Imaging S.p.A. (IT), Fujifilm Holdings Corporation (JP), Siemens Healthineers (DE), Canon Medical Systems Corporation (JP), Hoffmann-La Roche Ltd (CH)
Segments Covered Type, Form, Procedures, Application, Region
Key Market Opportunities Advancements in artificial intelligence enhance diagnostic accuracy in the Contrast Media Market.
Key Market Dynamics Technological advancements and regulatory changes drive innovation and competition in the Contrast Media Market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the current valuation of the Contrast Media Market as of 2024?

<p>The Contrast Media Market was valued at 6.74 USD Billion in 2024.</p>

What is the projected market valuation for the Contrast Media Market in 2035?

<p>The market is projected to reach 11.24 USD Billion by 2035.</p>

What is the expected CAGR for the Contrast Media Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Contrast Media Market during 2025 - 2035 is 4.76%.</p>

Which segment of the Contrast Media Market is expected to grow the most by 2035?

<p>Iodinated Contrast Media is anticipated to grow from 4.04 USD Billion in 2024 to 6.7 USD Billion by 2035.</p>

How do Gadolinium-Based Contrast Media valuations compare between 2024 and 2035?

<p>Gadolinium-Based Contrast Media is expected to increase from 2.7 USD Billion in 2024 to 4.54 USD Billion by 2035.</p>

What forms of contrast media are projected to see significant growth by 2035?

Liquid forms are expected to grow from 2.68 USD Billion in 2024 to 4.45 USD Billion by 2035.

Which medical procedures are driving the demand for contrast media?

X-ray/Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) are key procedures, with CT expected to grow from 3.5 USD Billion in 2024 to 5.8 USD Billion by 2035.

What applications are contributing to the growth of the Contrast Media Market?

Oncology is projected to grow from 2.68 USD Billion in 2024 to 4.4 USD Billion by 2035, indicating a strong demand in this area.

Who are the key players in the Contrast Media Market?

Key players include Bayer AG, GE Healthcare, and Bracco Imaging S.p.A., among others.

What is the expected growth trend for the Contrast Media Market in the coming years?

The market is likely to experience steady growth, driven by advancements in imaging technologies and increasing applications in various medical fields.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. | 1.1 EXECUTIVE SUMMARY
    2. | | 1.1.1 Market Overview
    3. | | 1.1.2 Key Findings
    4. | | 1.1.3 Market Segmentation
    5. | | 1.1.4 Competitive Landscape
    6. | | 1.1.5 Challenges and Opportunities
    7. | | 1.1.6 Future Outlook
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. | 2.1 MARKET INTRODUCTION
    2. | | 2.1.1 Definition
    3. | | 2.1.2 Scope of the study
    4. | | | 2.1.2.1 Research Objective
    5. | | | 2.1.2.2 Assumption
    6. | | | 2.1.2.3 Limitations
    7. | 2.2 RESEARCH METHODOLOGY
    8. | | 2.2.1 Overview
    9. | | 2.2.2 Data Mining
    10. | | 2.2.3 Secondary Research
    11. | | 2.2.4 Primary Research
    12. | | | 2.2.4.1 Primary Interviews and Information Gathering Process
    13. | | | 2.2.4.2 Breakdown of Primary Respondents
    14. | | 2.2.5 Forecasting Model
    15. | | 2.2.6 Market Size Estimation
    16. | | | 2.2.6.1 Bottom-Up Approach
    17. | | | 2.2.6.2 Top-Down Approach
    18. | | 2.2.7 Data Triangulation
    19. | | 2.2.8 Validation
  3. SECTION III: QUALITATIVE ANALYSIS
    1. | 3.1 MARKET DYNAMICS
    2. | | 3.1.1 Overview
    3. | | 3.1.2 Drivers
    4. | | 3.1.3 Restraints
    5. | | 3.1.4 Opportunities
    6. | 3.2 MARKET FACTOR ANALYSIS
    7. | | 3.2.1 Value chain Analysis
    8. | | 3.2.2 Porter's Five Forces Analysis
    9. | | | 3.2.2.1 Bargaining Power of Suppliers
    10. | | | 3.2.2.2 Bargaining Power of Buyers
    11. | | | 3.2.2.3 Threat of New Entrants
    12. | | | 3.2.2.4 Threat of Substitutes
    13. | | | 3.2.2.5 Intensity of Rivalry
    14. | | 3.2.3 COVID-19 Impact Analysis
    15. | | | 3.2.3.1 Market Impact Analysis
    16. | | | 3.2.3.2 Regional Impact
    17. | | | 3.2.3.3 Opportunity and Threat Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. | 4.1 Healthcare, BY Type (USD Billion)
    2. | | 4.1.1 Iodinated Contrast Media
    3. | | 4.1.2 Gadolinium-Based Contrast Media
    4. | 4.2 Healthcare, BY Form (USD Billion)
    5. | | 4.2.1 Liquid
    6. | | 4.2.2 Tablet
    7. | | 4.2.3 Powder
    8. | | 4.2.4 Paste
    9. | 4.3 Healthcare, BY Procedure (USD Billion)
    10. | | 4.3.1 X-ray/Computed Tomography (CT)
    11. | | 4.3.2 Magnetic Resonance Imaging (MRI)
    12. | 4.4 Healthcare, BY Application (USD Billion)
    13. | | 4.4.1 Cardiovascular Disease
    14. | | 4.4.2 Oncology
    15. | | 4.4.3 Gastrointestinal Disorders
    16. | 4.5 Healthcare, BY Region (USD Billion)
    17. | | 4.5.1 North America
    18. | | | 4.5.1.1 US
    19. | | | 4.5.1.2 Canada
    20. | | 4.5.2 Europe
    21. | | | 4.5.2.1 Germany
    22. | | | 4.5.2.2 UK
    23. | | | 4.5.2.3 France
    24. | | | 4.5.2.4 Russia
    25. | | | 4.5.2.5 Italy
    26. | | | 4.5.2.6 Spain
    27. | | | 4.5.2.7 Rest of Europe
    28. | | 4.5.3 APAC
    29. | | | 4.5.3.1 China
    30. | | | 4.5.3.2 India
    31. | | | 4.5.3.3 Japan
    32. | | | 4.5.3.4 South Korea
    33. | | | 4.5.3.5 Malaysia
    34. | | | 4.5.3.6 Thailand
    35. | | | 4.5.3.7 Indonesia
    36. | | | 4.5.3.8 Rest of APAC
    37. | | 4.5.4 South America
    38. | | | 4.5.4.1 Brazil
    39. | | | 4.5.4.2 Mexico
    40. | | | 4.5.4.3 Argentina
    41. | | | 4.5.4.4 Rest of South America
    42. | | 4.5.5 MEA
    43. | | | 4.5.5.1 GCC Countries
    44. | | | 4.5.5.2 South Africa
    45. | | | 4.5.5.3 Rest of MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. | 5.1 Competitive Landscape
    2. | | 5.1.1 Overview
    3. | | 5.1.2 Competitive Analysis
    4. | | 5.1.3 Market share Analysis
    5. | | 5.1.4 Major Growth Strategy in the Healthcare
    6. | | 5.1.5 Competitive Benchmarking
    7. | | 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
    8. | | 5.1.7 Key developments and growth strategies
    9. | | | 5.1.7.1 New Product Launch/Service Deployment
    10. | | | 5.1.7.2 Merger & Acquisitions
    11. | | | 5.1.7.3 Joint Ventures
    12. | | 5.1.8 Major Players Financial Matrix
    13. | | | 5.1.8.1 Sales and Operating Income
    14. | | | 5.1.8.2 Major Players R&D Expenditure. 2023
    15. | 5.2 Company Profiles
    16. | | 5.2.1 Bayer AG (DE)
    17. | | | 5.2.1.1 Financial Overview
    18. | | | 5.2.1.2 Products Offered
    19. | | | 5.2.1.3 Key Developments
    20. | | | 5.2.1.4 SWOT Analysis
    21. | | | 5.2.1.5 Key Strategies
    22. | | 5.2.2 GE Healthcare (US)
    23. | | | 5.2.2.1 Financial Overview
    24. | | | 5.2.2.2 Products Offered
    25. | | | 5.2.2.3 Key Developments
    26. | | | 5.2.2.4 SWOT Analysis
    27. | | | 5.2.2.5 Key Strategies
    28. | | 5.2.3 Bristol-Myers Squibb Company (US)
    29. | | | 5.2.3.1 Financial Overview
    30. | | | 5.2.3.2 Products Offered
    31. | | | 5.2.3.3 Key Developments
    32. | | | 5.2.3.4 SWOT Analysis
    33. | | | 5.2.3.5 Key Strategies
    34. | | 5.2.4 Bracco Imaging S.p.A. (IT)
    35. | | | 5.2.4.1 Financial Overview
    36. | | | 5.2.4.2 Products Offered
    37. | | | 5.2.4.3 Key Developments
    38. | | | 5.2.4.4 SWOT Analysis
    39. | | | 5.2.4.5 Key Strategies
    40. | | 5.2.5 Fujifilm Holdings Corporation (JP)
    41. | | | 5.2.5.1 Financial Overview
    42. | | | 5.2.5.2 Products Offered
    43. | | | 5.2.5.3 Key Developments
    44. | | | 5.2.5.4 SWOT Analysis
    45. | | | 5.2.5.5 Key Strategies
    46. | | 5.2.6 Siemens Healthineers (DE)
    47. | | | 5.2.6.1 Financial Overview
    48. | | | 5.2.6.2 Products Offered
    49. | | | 5.2.6.3 Key Developments
    50. | | | 5.2.6.4 SWOT Analysis
    51. | | | 5.2.6.5 Key Strategies
    52. | | 5.2.7 Canon Medical Systems Corporation (JP)
    53. | | | 5.2.7.1 Financial Overview
    54. | | | 5.2.7.2 Products Offered
    55. | | | 5.2.7.3 Key Developments
    56. | | | 5.2.7.4 SWOT Analysis
    57. | | | 5.2.7.5 Key Strategies
    58. | | 5.2.8 Hoffmann-La Roche Ltd (CH)
    59. | | | 5.2.8.1 Financial Overview
    60. | | | 5.2.8.2 Products Offered
    61. | | | 5.2.8.3 Key Developments
    62. | | | 5.2.8.4 SWOT Analysis
    63. | | | 5.2.8.5 Key Strategies
    64. | 5.3 Appendix
    65. | | 5.3.1 References
    66. | | 5.3.2 Related Reports
  6. LIST OF FIGURES
    1. | 6.1 MARKET SYNOPSIS
    2. | 6.2 NORTH AMERICA MARKET ANALYSIS
    3. | 6.3 US MARKET ANALYSIS BY TYPE
    4. | 6.4 US MARKET ANALYSIS BY FORM
    5. | 6.5 US MARKET ANALYSIS BY PROCEDURE
    6. | 6.6 US MARKET ANALYSIS BY APPLICATION
    7. | 6.7 CANADA MARKET ANALYSIS BY TYPE
    8. | 6.8 CANADA MARKET ANALYSIS BY FORM
    9. | 6.9 CANADA MARKET ANALYSIS BY PROCEDURE
    10. | 6.10 CANADA MARKET ANALYSIS BY APPLICATION
    11. | 6.11 EUROPE MARKET ANALYSIS
    12. | 6.12 GERMANY MARKET ANALYSIS BY TYPE
    13. | 6.13 GERMANY MARKET ANALYSIS BY FORM
    14. | 6.14 GERMANY MARKET ANALYSIS BY PROCEDURE
    15. | 6.15 GERMANY MARKET ANALYSIS BY APPLICATION
    16. | 6.16 UK MARKET ANALYSIS BY TYPE
    17. | 6.17 UK MARKET ANALYSIS BY FORM
    18. | 6.18 UK MARKET ANALYSIS BY PROCEDURE
    19. | 6.19 UK MARKET ANALYSIS BY APPLICATION
    20. | 6.20 FRANCE MARKET ANALYSIS BY TYPE
    21. | 6.21 FRANCE MARKET ANALYSIS BY FORM
    22. | 6.22 FRANCE MARKET ANALYSIS BY PROCEDURE
    23. | 6.23 FRANCE MARKET ANALYSIS BY APPLICATION
    24. | 6.24 RUSSIA MARKET ANALYSIS BY TYPE
    25. | 6.25 RUSSIA MARKET ANALYSIS BY FORM
    26. | 6.26 RUSSIA MARKET ANALYSIS BY PROCEDURE
    27. | 6.27 RUSSIA MARKET ANALYSIS BY APPLICATION
    28. | 6.28 ITALY MARKET ANALYSIS BY TYPE
    29. | 6.29 ITALY MARKET ANALYSIS BY FORM
    30. | 6.30 ITALY MARKET ANALYSIS BY PROCEDURE
    31. | 6.31 ITALY MARKET ANALYSIS BY APPLICATION
    32. | 6.32 SPAIN MARKET ANALYSIS BY TYPE
    33. | 6.33 SPAIN MARKET ANALYSIS BY FORM
    34. | 6.34 SPAIN MARKET ANALYSIS BY PROCEDURE
    35. | 6.35 SPAIN MARKET ANALYSIS BY APPLICATION
    36. | 6.36 REST OF EUROPE MARKET ANALYSIS BY TYPE
    37. | 6.37 REST OF EUROPE MARKET ANALYSIS BY FORM
    38. | 6.38 REST OF EUROPE MARKET ANALYSIS BY PROCEDURE
    39. | 6.39 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
    40. | 6.40 APAC MARKET ANALYSIS
    41. | 6.41 CHINA MARKET ANALYSIS BY TYPE
    42. | 6.42 CHINA MARKET ANALYSIS BY FORM
    43. | 6.43 CHINA MARKET ANALYSIS BY PROCEDURE
    44. | 6.44 CHINA MARKET ANALYSIS BY APPLICATION
    45. | 6.45 INDIA MARKET ANALYSIS BY TYPE
    46. | 6.46 INDIA MARKET ANALYSIS BY FORM
    47. | 6.47 INDIA MARKET ANALYSIS BY PROCEDURE
    48. | 6.48 INDIA MARKET ANALYSIS BY APPLICATION
    49. | 6.49 JAPAN MARKET ANALYSIS BY TYPE
    50. | 6.50 JAPAN MARKET ANALYSIS BY FORM
    51. | 6.51 JAPAN MARKET ANALYSIS BY PROCEDURE
    52. | 6.52 JAPAN MARKET ANALYSIS BY APPLICATION
    53. | 6.53 SOUTH KOREA MARKET ANALYSIS BY TYPE
    54. | 6.54 SOUTH KOREA MARKET ANALYSIS BY FORM
    55. | 6.55 SOUTH KOREA MARKET ANALYSIS BY PROCEDURE
    56. | 6.56 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    57. | 6.57 MALAYSIA MARKET ANALYSIS BY TYPE
    58. | 6.58 MALAYSIA MARKET ANALYSIS BY FORM
    59. | 6.59 MALAYSIA MARKET ANALYSIS BY PROCEDURE
    60. | 6.60 MALAYSIA MARKET ANALYSIS BY APPLICATION
    61. | 6.61 THAILAND MARKET ANALYSIS BY TYPE
    62. | 6.62 THAILAND MARKET ANALYSIS BY FORM
    63. | 6.63 THAILAND MARKET ANALYSIS BY PROCEDURE
    64. | 6.64 THAILAND MARKET ANALYSIS BY APPLICATION
    65. | 6.65 INDONESIA MARKET ANALYSIS BY TYPE
    66. | 6.66 INDONESIA MARKET ANALYSIS BY FORM
    67. | 6.67 INDONESIA MARKET ANALYSIS BY PROCEDURE
    68. | 6.68 INDONESIA MARKET ANALYSIS BY APPLICATION
    69. | 6.69 REST OF APAC MARKET ANALYSIS BY TYPE
    70. | 6.70 REST OF APAC MARKET ANALYSIS BY FORM
    71. | 6.71 REST OF APAC MARKET ANALYSIS BY PROCEDURE
    72. | 6.72 REST OF APAC MARKET ANALYSIS BY APPLICATION
    73. | 6.73 SOUTH AMERICA MARKET ANALYSIS
    74. | 6.74 BRAZIL MARKET ANALYSIS BY TYPE
    75. | 6.75 BRAZIL MARKET ANALYSIS BY FORM
    76. | 6.76 BRAZIL MARKET ANALYSIS BY PROCEDURE
    77. | 6.77 BRAZIL MARKET ANALYSIS BY APPLICATION
    78. | 6.78 MEXICO MARKET ANALYSIS BY TYPE
    79. | 6.79 MEXICO MARKET ANALYSIS BY FORM
    80. | 6.80 MEXICO MARKET ANALYSIS BY PROCEDURE
    81. | 6.81 MEXICO MARKET ANALYSIS BY APPLICATION
    82. | 6.82 ARGENTINA MARKET ANALYSIS BY TYPE
    83. | 6.83 ARGENTINA MARKET ANALYSIS BY FORM
    84. | 6.84 ARGENTINA MARKET ANALYSIS BY PROCEDURE
    85. | 6.85 ARGENTINA MARKET ANALYSIS BY APPLICATION
    86. | 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
    87. | 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORM
    88. | 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY PROCEDURE
    89. | 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    90. | 6.90 MEA MARKET ANALYSIS
    91. | 6.91 GCC COUNTRIES MARKET ANALYSIS BY TYPE
    92. | 6.92 GCC COUNTRIES MARKET ANALYSIS BY FORM
    93. | 6.93 GCC COUNTRIES MARKET ANALYSIS BY PROCEDURE
    94. | 6.94 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
    95. | 6.95 SOUTH AFRICA MARKET ANALYSIS BY TYPE
    96. | 6.96 SOUTH AFRICA MARKET ANALYSIS BY FORM
    97. | 6.97 SOUTH AFRICA MARKET ANALYSIS BY PROCEDURE
    98. | 6.98 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
    99. | 6.99 REST OF MEA MARKET ANALYSIS BY TYPE
    100. | 6.100 REST OF MEA MARKET ANALYSIS BY FORM
    101. | 6.101 REST OF MEA MARKET ANALYSIS BY PROCEDURE
    102. | 6.102 REST OF MEA MARKET ANALYSIS BY APPLICATION
    103. | 6.103 KEY BUYING CRITERIA OF HEALTHCARE
    104. | 6.104 RESEARCH PROCESS OF MRFR
    105. | 6.105 DRO ANALYSIS OF HEALTHCARE
    106. | 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    107. | 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    108. | 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
    109. | 6.109 HEALTHCARE, BY TYPE, 2024 (% SHARE)
    110. | 6.110 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
    111. | 6.111 HEALTHCARE, BY FORM, 2024 (% SHARE)
    112. | 6.112 HEALTHCARE, BY FORM, 2024 TO 2035 (USD Billion)
    113. | 6.113 HEALTHCARE, BY PROCEDURE, 2024 (% SHARE)
    114. | 6.114 HEALTHCARE, BY PROCEDURE, 2024 TO 2035 (USD Billion)
    115. | 6.115 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    116. | 6.116 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    117. | 6.117 BENCHMARKING OF MAJOR COMPETITORS
  7. LIST OF TABLES
    1. | 7.1 LIST OF ASSUMPTIONS
    2. | | 7.1.1
    3. | 7.2 North America MARKET SIZE ESTIMATES; FORECAST
    4. | | 7.2.1 BY TYPE, 2025-2035 (USD Billion)
    5. | | 7.2.2 BY FORM, 2025-2035 (USD Billion)
    6. | | 7.2.3 BY PROCEDURE, 2025-2035 (USD Billion)
    7. | | 7.2.4 BY APPLICATION, 2025-2035 (USD Billion)
    8. | 7.3 US MARKET SIZE ESTIMATES; FORECAST
    9. | | 7.3.1 BY TYPE, 2025-2035 (USD Billion)
    10. | | 7.3.2 BY FORM, 2025-2035 (USD Billion)
    11. | | 7.3.3 BY PROCEDURE, 2025-2035 (USD Billion)
    12. | | 7.3.4 BY APPLICATION, 2025-2035 (USD Billion)
    13. | 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
    14. | | 7.4.1 BY TYPE, 2025-2035 (USD Billion)
    15. | | 7.4.2 BY FORM, 2025-2035 (USD Billion)
    16. | | 7.4.3 BY PROCEDURE, 2025-2035 (USD Billion)
    17. | | 7.4.4 BY APPLICATION, 2025-2035 (USD Billion)
    18. | 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
    19. | | 7.5.1 BY TYPE, 2025-2035 (USD Billion)
    20. | | 7.5.2 BY FORM, 2025-2035 (USD Billion)
    21. | | 7.5.3 BY PROCEDURE, 2025-2035 (USD Billion)
    22. | | 7.5.4 BY APPLICATION, 2025-2035 (USD Billion)
    23. | 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
    24. | | 7.6.1 BY TYPE, 2025-2035 (USD Billion)
    25. | | 7.6.2 BY FORM, 2025-2035 (USD Billion)
    26. | | 7.6.3 BY PROCEDURE, 2025-2035 (USD Billion)
    27. | | 7.6.4 BY APPLICATION, 2025-2035 (USD Billion)
    28. | 7.7 UK MARKET SIZE ESTIMATES; FORECAST
    29. | | 7.7.1 BY TYPE, 2025-2035 (USD Billion)
    30. | | 7.7.2 BY FORM, 2025-2035 (USD Billion)
    31. | | 7.7.3 BY PROCEDURE, 2025-2035 (USD Billion)
    32. | | 7.7.4 BY APPLICATION, 2025-2035 (USD Billion)
    33. | 7.8 France MARKET SIZE ESTIMATES; FORECAST
    34. | | 7.8.1 BY TYPE, 2025-2035 (USD Billion)
    35. | | 7.8.2 BY FORM, 2025-2035 (USD Billion)
    36. | | 7.8.3 BY PROCEDURE, 2025-2035 (USD Billion)
    37. | | 7.8.4 BY APPLICATION, 2025-2035 (USD Billion)
    38. | 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
    39. | | 7.9.1 BY TYPE, 2025-2035 (USD Billion)
    40. | | 7.9.2 BY FORM, 2025-2035 (USD Billion)
    41. | | 7.9.3 BY PROCEDURE, 2025-2035 (USD Billion)
    42. | | 7.9.4 BY APPLICATION, 2025-2035 (USD Billion)
    43. | 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
    44. | | 7.10.1 BY TYPE, 2025-2035 (USD Billion)
    45. | | 7.10.2 BY FORM, 2025-2035 (USD Billion)
    46. | | 7.10.3 BY PROCEDURE, 2025-2035 (USD Billion)
    47. | | 7.10.4 BY APPLICATION, 2025-2035 (USD Billion)
    48. | 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
    49. | | 7.11.1 BY TYPE, 2025-2035 (USD Billion)
    50. | | 7.11.2 BY FORM, 2025-2035 (USD Billion)
    51. | | 7.11.3 BY PROCEDURE, 2025-2035 (USD Billion)
    52. | | 7.11.4 BY APPLICATION, 2025-2035 (USD Billion)
    53. | 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
    54. | | 7.12.1 BY TYPE, 2025-2035 (USD Billion)
    55. | | 7.12.2 BY FORM, 2025-2035 (USD Billion)
    56. | | 7.12.3 BY PROCEDURE, 2025-2035 (USD Billion)
    57. | | 7.12.4 BY APPLICATION, 2025-2035 (USD Billion)
    58. | 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
    59. | | 7.13.1 BY TYPE, 2025-2035 (USD Billion)
    60. | | 7.13.2 BY FORM, 2025-2035 (USD Billion)
    61. | | 7.13.3 BY PROCEDURE, 2025-2035 (USD Billion)
    62. | | 7.13.4 BY APPLICATION, 2025-2035 (USD Billion)
    63. | 7.14 China MARKET SIZE ESTIMATES; FORECAST
    64. | | 7.14.1 BY TYPE, 2025-2035 (USD Billion)
    65. | | 7.14.2 BY FORM, 2025-2035 (USD Billion)
    66. | | 7.14.3 BY PROCEDURE, 2025-2035 (USD Billion)
    67. | | 7.14.4 BY APPLICATION, 2025-2035 (USD Billion)
    68. | 7.15 India MARKET SIZE ESTIMATES; FORECAST
    69. | | 7.15.1 BY TYPE, 2025-2035 (USD Billion)
    70. | | 7.15.2 BY FORM, 2025-2035 (USD Billion)
    71. | | 7.15.3 BY PROCEDURE, 2025-2035 (USD Billion)
    72. | | 7.15.4 BY APPLICATION, 2025-2035 (USD Billion)
    73. | 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
    74. | | 7.16.1 BY TYPE, 2025-2035 (USD Billion)
    75. | | 7.16.2 BY FORM, 2025-2035 (USD Billion)
    76. | | 7.16.3 BY PROCEDURE, 2025-2035 (USD Billion)
    77. | | 7.16.4 BY APPLICATION, 2025-2035 (USD Billion)
    78. | 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
    79. | | 7.17.1 BY TYPE, 2025-2035 (USD Billion)
    80. | | 7.17.2 BY FORM, 2025-2035 (USD Billion)
    81. | | 7.17.3 BY PROCEDURE, 2025-2035 (USD Billion)
    82. | | 7.17.4 BY APPLICATION, 2025-2035 (USD Billion)
    83. | 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
    84. | | 7.18.1 BY TYPE, 2025-2035 (USD Billion)
    85. | | 7.18.2 BY FORM, 2025-2035 (USD Billion)
    86. | | 7.18.3 BY PROCEDURE, 2025-2035 (USD Billion)
    87. | | 7.18.4 BY APPLICATION, 2025-2035 (USD Billion)
    88. | 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
    89. | | 7.19.1 BY TYPE, 2025-2035 (USD Billion)
    90. | | 7.19.2 BY FORM, 2025-2035 (USD Billion)
    91. | | 7.19.3 BY PROCEDURE, 2025-2035 (USD Billion)
    92. | | 7.19.4 BY APPLICATION, 2025-2035 (USD Billion)
    93. | 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
    94. | | 7.20.1 BY TYPE, 2025-2035 (USD Billion)
    95. | | 7.20.2 BY FORM, 2025-2035 (USD Billion)
    96. | | 7.20.3 BY PROCEDURE, 2025-2035 (USD Billion)
    97. | | 7.20.4 BY APPLICATION, 2025-2035 (USD Billion)
    98. | 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
    99. | | 7.21.1 BY TYPE, 2025-2035 (USD Billion)
    100. | | 7.21.2 BY FORM, 2025-2035 (USD Billion)
    101. | | 7.21.3 BY PROCEDURE, 2025-2035 (USD Billion)
    102. | | 7.21.4 BY APPLICATION, 2025-2035 (USD Billion)
    103. | 7.22 South America MARKET SIZE ESTIMATES; FORECAST
    104. | | 7.22.1 BY TYPE, 2025-2035 (USD Billion)
    105. | | 7.22.2 BY FORM, 2025-2035 (USD Billion)
    106. | | 7.22.3 BY PROCEDURE, 2025-2035 (USD Billion)
    107. | | 7.22.4 BY APPLICATION, 2025-2035 (USD Billion)
    108. | 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
    109. | | 7.23.1 BY TYPE, 2025-2035 (USD Billion)
    110. | | 7.23.2 BY FORM, 2025-2035 (USD Billion)
    111. | | 7.23.3 BY PROCEDURE, 2025-2035 (USD Billion)
    112. | | 7.23.4 BY APPLICATION, 2025-2035 (USD Billion)
    113. | 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
    114. | | 7.24.1 BY TYPE, 2025-2035 (USD Billion)
    115. | | 7.24.2 BY FORM, 2025-2035 (USD Billion)
    116. | | 7.24.3 BY PROCEDURE, 2025-2035 (USD Billion)
    117. | | 7.24.4 BY APPLICATION, 2025-2035 (USD Billion)
    118. | 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
    119. | | 7.25.1 BY TYPE, 2025-2035 (USD Billion)
    120. | | 7.25.2 BY FORM, 2025-2035 (USD Billion)
    121. | | 7.25.3 BY PROCEDURE, 2025-2035 (USD Billion)
    122. | | 7.25.4 BY APPLICATION, 2025-2035 (USD Billion)
    123. | 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
    124. | | 7.26.1 BY TYPE, 2025-2035 (USD Billion)
    125. | | 7.26.2 BY FORM, 2025-2035 (USD Billion)
    126. | | 7.26.3 BY PROCEDURE, 2025-2035 (USD Billion)
    127. | | 7.26.4 BY APPLICATION, 2025-2035 (USD Billion)
    128. | 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
    129. | | 7.27.1 BY TYPE, 2025-2035 (USD Billion)
    130. | | 7.27.2 BY FORM, 2025-2035 (USD Billion)
    131. | | 7.27.3 BY PROCEDURE, 2025-2035 (USD Billion)
    132. | | 7.27.4 BY APPLICATION, 2025-2035 (USD Billion)
    133. | 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
    134. | | 7.28.1 BY TYPE, 2025-2035 (USD Billion)
    135. | | 7.28.2 BY FORM, 2025-2035 (USD Billion)
    136. | | 7.28.3 BY PROCEDURE, 2025-2035 (USD Billion)
    137. | | 7.28.4 BY APPLICATION, 2025-2035 (USD Billion)
    138. | 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
    139. | | 7.29.1 BY TYPE, 2025-2035 (USD Billion)
    140. | | 7.29.2 BY FORM, 2025-2035 (USD Billion)
    141. | | 7.29.3 BY PROCEDURE, 2025-2035 (USD Billion)
    142. | | 7.29.4 BY APPLICATION, 2025-2035 (USD Billion)
    143. | 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
    144. | | 7.30.1 BY TYPE, 2025-2035 (USD Billion)
    145. | | 7.30.2 BY FORM, 2025-2035 (USD Billion)
    146. | | 7.30.3 BY PROCEDURE, 2025-2035 (USD Billion)
    147. | | 7.30.4 BY APPLICATION, 2025-2035 (USD Billion)
    148. | 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    149. | | 7.31.1
    150. | 7.32 ACQUISITION/PARTNERSHIP
    151. | | 7.32.1

Healthcare Market Segmentation

Healthcare By Type (USD Billion, 2025-2035)

  • Iodinated Contrast Media
  • Gadolinium-Based Contrast Media

Healthcare By Form (USD Billion, 2025-2035)

  • Liquid
  • Tablet
  • Powder
  • Paste

Healthcare By Procedure (USD Billion, 2025-2035)

  • X-ray/Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)

Healthcare By Application (USD Billion, 2025-2035)

  • Cardiovascular Disease
  • Oncology
  • Gastrointestinal Disorders
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓